Your browser doesn't support javascript.
loading
PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.
Huang, Shengjian; Liu, Yang; Chen, Zhihong; Wang, Michael; Jiang, Vivian C.
Afiliación
  • Huang S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Chen Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Jiang VC; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.
Am J Cancer Res ; 12(3): 1102-1115, 2022.
Article en En | MEDLINE | ID: mdl-35411248
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos